News | Heart Failure | April 19, 2022

Insights into the Dynamic Ultrastructure of the Heart

With new ultra-high-resolution electron microscopy techniques, scientists can now watch the heart beating – almost at a molecular level

Insight at the nanometer scale is of great importance for the development of new therapies, for example for heart attacks or cardiac arrhythmias.

Intracellular organelles of a cardiomyocyte


April 19, 2022 – What happens below the cellular level when the heart contracts and relaxes has long been unexplored. Thanks to new ultra-high-resolution electron microscopy techniques, scientists can now watch the heart beating – almost at a molecular level. Researchers at the Medical Faculty of the University of Freiburg summarize the most important developments in cardiac electron microscopy and their significance for research in a recent publication, published in Nature Reviews Cardiology. Insight at the nanometer scale is of great importance for the development of new therapies, for example for heart attacks or cardiac arrhythmias.

"With the high-resolution microscopy techniques developed by us and others worldwide, we gain fascinating insights into the dynamic ultrastructure of the heart," says the study's lead author Dr. Eva Rog-Zielinska. She heads the 4D Imaging Section at the Institute of Experimental Cardiovascular Medicine (IEKM) of the University Heart Centre at the University Medical Centre Freiburg. "We can use this insight to analyze the three-dimensional structure of heart cells with unprecedented precision. Our images are made up of cubes – so-called voxels – with an edge length of one nanometer or less. For illustration: one nanometer is the distance a fingernail grows in one second," Rog-Zielinska explains.

Watching the heart beat in super slow motion

A challenge is to link ultra-high resolution mapping of the heart to a moving target. "Thanks to recent advances in imaging, we now have a much better understanding of how muscle and connective tissue cells behave in the beating heart," says co-author Prof. Peter Kohl, Director of the IEKM, who is also the spokesperson of the German Collaborative Research Centre 1425 dedicated to exploring cardiac scarring.

Electron microscopy itself, but crucially also newly developed methods for the preparation and post-processing of corresponding samples, play a central role in the generation of molecular insight. "It is particularly exciting that we can record muscle cells like individual frames in a film – thanks to millisecond-precise high-pressure freezing. This allows us to watch the heart‘s molecular structures beating in super slow motion, as it were," says Kohl.

Experiments, simulations and artificial intelligence intertwine

The microscopic images are evaluated at IEKM with the help of artificial intelligence, assisted by computer simulations to depict heart function and pathological changes as realistically as possible. "Newly gained insight allows us to gain a completely new understanding of cardiac activity and, based on this, to develop new therapeutic concepts. We are looking forward to a very exciting time in heart research," says Kohl.

For more information: Electron microscopy of cardiac 3D nanodynamics: form, function, future


Related Content

News | Heart Failure

Oct. 22, 2025 – Ventric Health, a medtech innovator enabling early detection of heart failure (HF) in a primary care ...

Home October 28, 2025
Home
News | Heart Failure

Oct. 16, 2025 — Imbria Pharmaceuticals, has announced a partnership with the Hypertrophic Cardiomyopathy Association ...

Home October 16, 2025
Home
News | Heart Failure

Sept. 24, 2025 — The Family Heart Foundation, a leading research and advocacy organization, has announced the online ...

Home September 24, 2025
Home
News | Heart Failure

Sept. 22, 2025 — The latest findings on heart failure (HF) published by the Heart Failure Society of America (HFSA) ...

Home September 22, 2025
Home
News | Heart Failure

Sept. 11, 2025 — Newswise — A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women ...

Home September 15, 2025
Home
News | Heart Failure

Aug. 14, 2025 — Analytics For Life, in collaboration with its U.S. commercial partner CorVista Health, announced they ...

Home August 15, 2025
Home
News | Heart Failure

Aug. 6, 2025 — Ventric Health, a medtech company enabling early detection of heart failure (HF) in a primary care ...

Home August 06, 2025
Home
News | Heart Failure

July 14, 2025 — Bayer has announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA (finerenone) to ...

Home July 14, 2025
Home
News | Heart Failure

June 23, 2025 — iRhythm Technologies, Inc. announced the results from two large-scale real-world studies presented at ...

Home June 25, 2025
Home
News | Heart Failure

June 3, 2025 — Bayer announced it will present multiple new analyses of the Kerendia (finerenone) clinical trial program ...

Home June 04, 2025
Home
Subscribe Now